Jane Street’s Intelligent Bio Solutions INBS Stock Holding History

Jane Street’s Portfolio INBS Stock Details INBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-5	Closed	-$2.24K	–	9442
2022 Q4	$2.24K	Buy	+5	New	+$4.79K	﹤0.01%	8928
2022 Q1	–	Sell	-10	Closed	-$36K	–	10646
2021 Q4	$36K	Buy	+10	New	+$45.9K	﹤0.01%	9647
2021 Q3	–	Sell	-8	Closed	-$75K	–	10296
2021 Q2	$75K	Buy	+8	New	+$76.5K	﹤0.01%	9383
2021 Q1	–	Sell	-7	Closed	-$120K	–	9341
2020 Q4	$120K	Buy	+7	New	+$154K	﹤0.01%	7152

Other funds holding INBS

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Jane Street's INBS Position: Q1 2023 in Review

Jane Street sold out of Intelligent Bio Solutions (INBS) in Q1 2023, closing a stake of 5 shares — an estimated $2.24K sold.

Jane Street first reported a position in INBS in Q4 2020 and held it in 4 quarters. The position peaked at $120K in Q4 2020. 4 funds tracked by Wall St. Rank hold INBS as of Q1 2023.

Jane Street reported no remaining Intelligent Bio Solutions position as of Q1 2023 after selling out during the quarter.
Jane Street sold 5 Intelligent Bio Solutions shares in Q1 2023, an estimated $2.24K.
Jane Street first reported a position in Intelligent Bio Solutions in Q4 2020 and held it in 4 quarters.
Jane Street's Intelligent Bio Solutions position peaked at $120K in Q4 2020.
4 funds tracked by Wall St. Rank held Intelligent Bio Solutions as of Q1 2023.

Based on Jane Street's 13F filing for Q1 2023, filed 16 May 2023.